openPR Logo

Press Releases by Category Health & Medicine

RSS-Newsfeed

Haplo-Identical Bone Marrow Transplantation, “The Glass is Always Half Full”

A 25 year old IT professional was struck with Hodgkin ’s disease which is one of the most curable cancers. He was treated with standard chemotherapy and the disease went away only to reappear a few months later. This time he received local radiation and Autologous Bone Marrow Transplantation (BMT). However, the response was shortlived and the cancer sprung its ugly head within 6 months. The young man and his distraught

Bilcare nCiD Technology receives 2014 Frost & Sullivan India Technology Innovati …

Bilcare nCiD Technology receives 2014 Frost & Sullivan India Technology Innovation Award Mumbai, October 10, 2014: Bilcare nonClonable ID ™ Technology was conferred with prestigious Growth, Innovation & Leadership award 2014 by Frost & Sullivan, India. This award is conferred to recognize and reward innovation, technology and leadership best practice adopted by marquee companies across sectors. The function was attended by distinguished guests comprising innovators and visionary leaders from

First Ever Strategic Sourcing Conference Only for Medical Device Professionals T …

For the first time, procurement professionals from the medical device space will have the opportunity to participate in a conference specific to the industry and network with fellow executives from some of the biggest companies in healthcare. The Medical Device Strategic Sourcing Conference will be held January 26-27, 2015 in Atlanta, Georgia, offering attendees an exclusive chance to take part in interactive panel discussions and workshops addressing the most top-of-mind

Four Dozen Speakers On This Year's 5th Annual Life Science Executive Leadership …

Registration is now open for the 5th Annual Life Science Executive Leadership Forum, providing pharmaceutical and medical device C-level executives, vice presidents, and directors an opportunity to discuss the most top-of-mind issues and best practices for maintaining a competitive advantage in the ever-evolving healthcare space. The forum will take place January 26-27, 2015 in Ft. Lauderdale, Florida. This year’s forum, hosted by Q1 Productions, offers a plethora of opportunities for networking

CM LOC®- a new benchmark in prosthetics.

The Swiss company Cendres+Métaux SA is setting a new standard in the field of prosthetics in the form of CM LOC®. An optimised female part design with high-quality retention inserts provides maximum wearing comfort for patients. The system is extremely easy to handle and combines top quality materials with fantastic durability: The concept behind the CM LOC® anchoring system consists of a metal-free or a titanium female part. Pekkton® ivory, a
09-26-2014 | Health & Medicine
UMS AG

UMS AG extraordinary shareholder's meeting. CEO'S speech published on website

Hamburg - 24 September 2014: In preparation for the extraordinary shareholders' meeting of UMS United Medical Systems International AG (DE0005493654) scheduled for tomorrow, 25 September 2014, and in the interest of outmost transparency for its shareholders, the company has voluntarily published the CEO's speech explaining the different agenda items on the company's website today. The publication is meant to complement the voluntary written report of the management which has been

A New Generation of Glucose Sensors is Creating Options for Caregivers and their …

(Amherst, NH) – The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. New glucose sensors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By utilizing new technologies for sensing glucose, this new class of sensors is creating new options for caregivers and their diabetes patients. Signal

Marinomed Biotechnologie GmbH: French Nicox S.A. successfully bids for anti-vira …

Vienna – Marinomed Biotechnologie GmbH agreed to sell its promising anti-viral eye drop program to Nicox S.A. of France. The France-based international ophthalmic company acquires the entire program as well as all associated rights, data, contracts and information. In return Marinomed will receive up to € 5.3 Mio. The anti-viral eye drop program of Marinomed derives from the successful technology platform Mavirex® which exploits anti-viral effects of polymers from red

Circulating Tumor Cells Spawning Diagnostic Tools to Guide Caregivers in Cancer …

(Amherst, NH) – Circulating tumor cells (CTCs) were first discovered more than a century ago. Because they originate from a malignant mass, they can carry useful information for clinicians with regard to the efficacy of treatments or to changes occurring within the tumor as a result of active treatment. The absence of a simple way to isolate and detect CTCs coupled with the lack of a clear understanding of the

What About Ebola Virus? Symptoms And Infection

What’s Ebola Virus? Ebola eliminate virus vaccine could not yet be traced, while 40 years ago the first case of infection was reported in humans. What Is This Virus And How It Spreads Infection. Ebola virus is spreading rapidly in Africa, is increasing toll this has caused discomfort around the world. But Ebola prevent infection in Africa engaged in a variety of health personnel are facing difficulties. Ebola ongoing war against individual tribes

New board member joins AFFiRiS AG

Vienna, 9. September 2014 – AFFiRiS AG today announced the appointment of Oliver Siegel as a new member of the Executive Management Board. He will take over responsibility for Business Development, Finance and Administration. The appointment of the international experienced transaction expert extends the know-how of the board with a focus on partnering and business operations. Oliver Siegel will expend his experience gained at leading international investment banks to focus

Sixth Annual Diagnostic Coverage and Reimbursement Conference Set for December 2 …

For the sixth straight year, Q1 Productions is hosting the Annual Diagnostic Coverage and Reimbursement Conference, bringing together managed care, reimbursement, and health economics executives to discuss the latest regulatory changes and coverage strategies within the diagnostic industry. The conference will take place December 8-9, 2014 in Boston, Massachusetts and is open to laboratories and diagnostic companies of all sizes. At this year’s conference, speakers include experts from payer organizations, Accountable

Backcare Awareness Week 2014

Employee Backcare Awareness Week is running from the 6th – 10th October 2014. Relaxa & Posture Group are offering a range of back care health packages from as little as £259 AND / OR online posture training from £1 per user, incorporating a range of backcare health promotion activities for all your staff. This year the National campaign is on office workers. Relaxa employs a team of more than 1,000

Berlin Heart employees cook for families at the Ronald McDonald house

In the afternoon of July, 31st 2014 ten Berlin Heart employees gathered at the Ronald McDonald House in Berlin-Wedding to prepare a three-course-menu for the residents. That night mache with chanterelle and caramelized walnuts followed by coq au vin and a peach and raspberry crumble with pistachios and vanilla ice cream as desert were on the menu. The aim of the volunteers was not only to serve a delicious dinner

Patient Monitors based on Wireless Body Sensor Networks Progressing as Technolog …

(Amherst, NH) – Wearable systems for continuous health monitoring are being viewed by healthcare policy decision makers as a potentially important element in improving the practice and delivery of healthcare across a broad spectrum of the population. These systems have the ability to allow caregivers and even the patient to closely monitor changes in key physiological parameters including vital signs. In its simplest form, a patient-worn Wireless Body Sensor Network (WBSN)

Phosphate Increases The Concentration of Sodium (!) in The Blood

A previously undiscovered role played by the hormone FGF23 has now been discovered in a project funded by the Austrian Science Fund FWF. Scientists were already aware that greater quantities of this hormone are produced when there is too much phosphate in the blood plasma and that it reduces the absorption of this mineral from the urine. The new results now also show an effect on the absorption of sodium.

MoBiTec, Germany, Announces Availability of Ebola Virus (EBOV) Real Time RT-PCR …

Ebola hemorrhagic fever (Ebola HF) is a severe, often fatal disease in humans and nonhuman primates, caused by infection with Ebolavirus. The recent Ebola outbreak in West Africa is one of the largest Ebola outbreaks in history. Ebola is the virus Ebolavirus (EBOV), a viral genus, and the disease Ebola hemorrhagic fever (EHF), a viral hemorrhagic fever (VHF). The virus is named after the Ebola River Valley in the Democratic Republic

Clinical Data Management Conference to Focus on Implementing Technology, New Gui …

For the second consecutive year, Q1 Productions will host the Innovations in Clinical Data Management Conference, bringing the most valuable information in the pharmaceutical and medical device industries to clinical data managers of small, medium, and large sized companies. The conference will be held October 27-28, 2014 in Arlington, Virginia. Based on requests from past attendees, the conference format will once again include ample time for small group discussion to further

Registration Now Open for 4th Annual Medical Device Regulatory Clearance & Appro …

(Chicago, IL) – For the fourth straight year, Q1 Productions will host the annual Medical Device Regulatory Clearance and Approval Conference, offering regulatory affairs professionals exclusive insight to the latest trends and newest happenings within the industry. The conference will take place November 3-4, 2014 in Arlington, Virginia. This year, a variety of new session topics will be on the agenda addressing several hot topics, including 510(k) guidances, regulations for

Sale of all shares in United Medical Systems (DE), Inc., Massachusetts, USA

Dissemination of an Ad hoc announcement according to § 15 WpHG The issuer is solely responsible for the content of this announcement Ad-hoc-Announcement 14 August 2014 Today the Company has entered into a stock purchase agreement with UMS Acquisitions Holdings, Inc., Delaware, USA (Purchaser) regarding the sale of all shares in United Medical Systems (DE), Inc., Westborough, Massachusetts, USA, a fully owned subsidiary of the Company. The purchase price for the transfer of the

UMS AG on Track in First Half of 2014

- Exchange-rate-adjusted revenues and earnings stable - Forecast confirmed - Dividend policy unchanged Hamburg, August 14, 2014 - UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) has published its figures for the first half of 2014. After an initially subdued start, business has revived, with revenues and earnings at the previous year's level when adjusted for the negative effects of the weak U.S. dollar. As a result, UMS is confirming its full-year

Investigating Telomeres: Using High-Performance Microscopy for Understanding Can …

On Thursday, August 14, join experts from the scientific community for a panel discussion at the German Center for Research and Innovation (GCRI) in New York on investigating telomeres using high-resolution imaging. NEW YORK (August 11, 2014) – Telomeres, the region of DNA at the end of each of our chromosomes, protects our genes from unwanted deterioration or fusion with nearby chromosomes. On Thursday, August 14, 2014, join scientific experts

Self Administered Injectable Drugs to Reach $100 Billion Globally by the End of …

Growth will be impacted by Generics and New Oral APIs, according To Greystone Research Associates (Amherst, NH) – Self administered injectable drugs, a class that includes prescribed therapeutics for anti-inflammatories, antivirals, anemia, hormone replacement, fertility, osteoporosis, anticoagulants, and drugs for controlling diabetes, have grown at a CAGR of 7.7% over the past six years, as enhancements in self-injection devices have converged with improved drugs that cannot be administered orally. Based on

Upcoming in 2015: VISION PHARMA – Leading trade fair for Pharma, Medical Devices …

VISION PHARMA is the future of trade fair visits. it covers not only the complete value-adding chain in PHARMA (Research & Development, Production, GxP, Quality Management, Product Safety, Plants, Equipment and Machines, Analyses and Laboratory), but provides platforms for lectures, product presentations, application performances, round tables and expert discussion panels. VISION PHARMA correlates user and contractor, industry and science, requirement and solution. VISION PHARMA attracts exhibitors and researchers from all over Europe. More

Limited Seats Remain For the 2nd Annual Medical Device Strategic Pricing Confere …

(Chicago, IL) – There is still time to register for this years’ 2nd Annual Medical Device Strategic Pricing Conference, providing pricing professionals with an opportunity to discuss the latest issues and trends in the medical device pricing industry. Nearly a dozen new topics are on the agenda, as well as several new speakers from all corners of the pricing space. The conference, hosted by Q1 Productions, will be held at the

MEDIFIX Solutions™ - Adhesive Solutions for Wearable Medical Devices

Scapa Healthcare announces the launch of MEDIFIX Solutions™ as a complete turnkey solution for wearable mobile device applications. MEDIFIX Solutions™ offers a portfolio of materials, adhesives, conversion, printing, and packaging to support wearable device attachment to the skin. The combination of MEDIFIX® materials and converting, in conjunction with a global design and manufacturing footprint, enables efficient custom development and scalable production across the diverse and growing needs of wearable applications, including

Disposable Drug Cartridges Changing the Injectable Therapeutics Landscape

(Amherst, NH) – As drug injection devices evolve, they are increasingly being designed to accommodate disposable drug cartridges. Because of the inherent advantages they possess, the number of devices and drug therapies that rely on prefilled drug cartridges has been growing, both within established therapeutic segments and by expanding into new injectable drug therapies. Prefilled disposable drug cartridges made their market debut as a convenient way for diabetics to administer insulin.

Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre

Eminent Healthcare Expert Dr Sandeep Chatrath receives the prestigious India’s Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre ILc Power Brand 2014. Dr Sandeep Chatrath also declared by the Jury as the CEO of the Year Healthcare 2014 at Asia’s Biggest Leadership Event, the 5th Annual India Leadership Conclave 2014 The prestigious & coveted Awards were presented in a glittering award ceremony

Industry and Legal Perspectives Main Focus of Upcoming Pharmaceutical Pricing an …

Pricing professionals now have the opportunity to network and share ideas on the pharmaceutical pricing industry’s top concerns at the first-ever Pharmaceutical Pricing and Contracting Conference in Philadelphia, Pennsylvania, September 22-23, 2014. The conference, hosted by Q1 Productions, offers dozens of in-depth sessions, panel discussions and case studies led by pricing executives from small and large pharmaceutical companies. Participants will have the opportunity to hear from some of the pharmaceutical

First-Ever Scientific Communications Conference to Address Sunshine Act, Case St …

For the first time ever, Q1 Productions is hosting the Pharmaceutical and Medical Device Scientific Communications Conference, offering tailor-made, high-level presentations and open floor discussions to scientific communications professionals. Attendees to the conference will have the opportunity to network and share ideas with fellow scientific communications professionals, hear case studies from leading pharmaceutical and medical device companies, and participate in interactive panel discussions that address the most top-of-mind issues in the

Organ donation and transplantation in emerging economies: organ trafficking, mis …

"The impact of commerce, transplant tourism and organ trafficking remains a burning issue in the global community of transplantation. Emerging economies became the centre of transplant commerce and tourism with centers in many countries. The views differ in the selling and buying countries," Dr. S.A. Anwar Naqvi and colleagues (Karachi/Pakistan) report. Experienced physicians provide an overview in the new handbook "Organ Transplantation: Ethical, Legal and Psychosocial Aspects. Global Issues, Local

Merete Medical GmbH plans to expand its facilities in Luckenwalde and Berlin

July 4, 2014 - Merete Medical will expand its production capacity on the basis of the most modern manufacturing technologies in its manufacturing facilities in Luckenwalde Biotechnologie Park and at the Berlin site. These investments, spread over the next two years, aim to promote in particularly new and further developments in the successful and fast-growing segments arthroplasty / revision and foot reconstruction surgery. Overall, these investment measures aim at creating

blue inspection body reports on experiences with excipient audits

The industry initiative EXCiPACT was launched a year ago to improve monitoring of pharmaceutical excipients. At the CPhI China in Shanghai and the ExcipientFest Europe in Amsterdam, the auditors of blue inspection body (www.blue-inspection.com) have now drawn an initial conclusion: “Overall, the level of awareness for Good Manufacturing and Good Distribution Practices at excipient manufacturers has increased significantly in the past twelve months,” declared lead auditor Dr. Norbert Waldöfner in

Diapharm assists in EU registration of Chinese medicines

Diapharm (diapharm.com) has opened its representative office in Shanghai in July 2014 in reaction to a surging demand for pharmaceutical consultancy services in China. Diapharm helps pharmaceutical companies to obtain drug approval in Europe and assists them in quality assurance. “We will advise and assist Chinese companies as they make their way to Europe and also support European companies that purchase active ingredients or finished products from China and that

Patent Portfolio Covering Bone and Tissue Regeneration Technology Developed by t …

Munich, Germany (July 3, 2014) – Munich Innovation announces the opportunity to acquire the patented know-how of Magnetodyn, the leading company in the technology of bone and tissue regeneration using activatable implants for electromagnetic deep tissue stimulation. The technology is protected by a strong patent portfolio that spans 10 independent patent families, including 31 granted patents and 29 active patent applications in the US, EU and Worldwide. Stimulation of the

Transasia sponsors 'A tribute to the poetry of Gulzar' in aid of Thalassemic Chi …

Mumbai, June 2014: As a part of its corporate social responsibility, Transasia Bio-Medicals Ltd. sponsored a Fund Raising Musical Concert, in aid of Thalassemic children, titled a “Tribute to the poetry of Gulzar”. Well-known as one of India’s finest film makers, lyricist and exemplary poet, Gulzar is known for his romantic and melancholic compositions. From its inception Transasia Bio-Medicals Ltd., has consciously chosen, 'Making a meaningful contribution to Society'

New Speakers, Additional Learning Opportunities Available at the 5th Annual Clin …

The most popular meeting for clinical and regulatory diagnostics professionals is scheduled for October 27-29, offering an exclusive opportunity for peer-to-peer networking, idea sharing and insight to best practices within the industry. The 5th Annual Clinical Affairs and Regulatory Approvals for Diagnostics Conference will be held in Arlington, Virginia and is hosted by Q1 Productions. New topics focusing on the latest trends and issues from all corners of the diagnostic

Cerbomed GmbH at the 11th European Congress on Epileptology in Stockholm

ERLANGEN/STOCKHOLM, 30.06.2014 – From June 30th until July 3rd 2014 the medical device company cerbomed GmbH from Erlangen, Germany, will present a further therapy option for people suffering from epilepsies at the 11th European Congress on Epileptology in Stockholm: The transcutaneous Vagus Nerve Stimulation (t-VNS) with the therapy device NEMOS. About t-VNS with NEMOS Transcutaneous Vagus Nerve Stimulation with NEMOS offers a further therapy option to epilepsy

Q1 Productions Hosting First-Ever Pharmaceutical Supplier Quality Assurance Conf …

(Chicago, IL) – By popular request, Q1 Productions will be hosting the inaugural Pharmaceutical Supplier Quality Assurance Conference July 21-22, in Arlington, Virginia, fulfilling the demand for a tailor-made meeting for supplier quality assurance professionals within the pharmaceutical industry. Pharmaceutical quality assurance executives are invited to take part in peer-to-peer networking, high-level information sessions and idea sharing during the two day conference and take away immediate deliverables to give

Simple Wishes to Donate $150K in Products to Two Breastfeeding Industry Non-Prof …

San Francisco, CA. (June 24, 2014) – Simple Wishes, the creators of the Signature Hands-Free Breast Pumping Bra and other breastfeeding accessories, will donate $150,000 worth of Honeysuckle Breastmilk Storage Bags to two non-profits, the Human Milk Banking Association (HMBANA) and Miracle Babies. The donation of these storage bags to HMBANA and Miracle Babies will aid each organization in their mass storage of breastmilk. HMBANA provides tested and healthy breast

Serialization A Hot Topic At Upcoming Pharmaceutical Supply Chain Management Con …

(Chicago, IL) – By popular request, the Pharmaceutical Supply Chain Management Conference is back with the biggest names from all corners of the industry presenting valuable information on the most time-sensitive topics. This year, more than a dozen experts from small, midsize and large companies will be on hand for in-depth discussions and networking specifically catered towards pharmaceutical executives. The conference will be held October 9-10, 2014 in

Despite Favorable Market Conditions Dual Chamber Device Suppliers Struggle to Sh …

(Amherst, NH) – As the number of injectable drugs supplied in powder form escalates, drug designers are increasingly incorporating reconstitution technology into their device plans. The most elegant approach to this need is the dual chamber device. A two-chamber primary package allows the patient to perform a simple procedure – for example twisting the device body – to initiate mixing of the drug power with diluent prior to initiating the

Currently at Ten Percent Market Penetration, Drug Reconstitution Systems Chasing …

(Amherst, NH) – As the number of non-small molecule drugs in the development pipeline continues to give way to more complex molecules that possess limited stability and an inability to survive the upper GI tract, the number of injectables and infusibles entering the market as solid formulations is increasing. These drugs must be reconstituted prior to use. There are currently four-hundred-forty-two FDA-approved lyophilized drug products supplied for injection and/or infusion.

The 5th Drug-Drug Interaction (DDI) Workshop at Marbach Castle is highly rated b …

Gelnhausen (Germany), 20th June 2014 – More than 70 experts in drug development and drug-drug interactions from 14 countries took part in the scientific meeting entitled "DDI 2014 – 5th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions" at Marbach Castle on Lake Constance between 25 and 27 May. Feedback on the workshop from participants was consistently positive. The DDI

Autoinjector Landscape Changing as Suppliers Re-evaluate Market Opportunities

(Amherst, NH) – Autoinjectors, which first appeared as an accessory device to aid in the administration of injectable drugs supplied in prefilled syringes, have grown to become a significant medical device market segment. As the number of drugs available in prefilled syringes as a percentage of all injectable drugs has grown, autoinjectors have experienced healthy and consistent demand, resulting in expanding competition and proliferating device product lines. Now, in response

Unique Glaucoma Detection Pen Through Eyelid aka Diaton Tonometer Featured at XX …

Unique Tonometer Diaton Pen (BiCOM Inc) presented by FarbaC Biomedical S.A. de C.V at XXXI Congress of Ophthalmology held in Cancun, Mexico. Tonometer Diaton allows to measure intraocular pressure (IOP) through upper eyelid and sclera without use of the drops or contact with the cornea. Diaton Tonometer is the only non-corneal tonometer on the market – it provides reliable measurements and makes it possible to diagnose glaucoma in its early stages,

Global Injectable Drug Market to Reach $225 Billion in 2020

(Amherst, NH) – The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs, and healthcare administration initiatives, developments that will drive the global injectable drug delivery sector to $225 billion by 2020. As new injectable drugs become available for the treatment of an

Texila American University Upcoming Journal Publications

Texila American University (TAU) has never backed down by providing quality contents for researchers and students. It has been the priority of the university to create a vast informational hub where students and researcher can research and access quality contents. So no wonder, it has initiated and started the EIJASR website (E-International Journal of Academic and Scientific Research) Currently the pioneering institution has published about 6 journals in one year and

Autoimmune Disease Therapeutics Continue to Improve, but Many Challenges Remain

(Amherst, NH) – Autoimmune diseases, a group of chronic ailments that includes arthritis, psoriasis, lupus, and multiple sclerosis, afflict tens of millions of people worldwide and result in levels of morbidity that can significantly impact quality of life and longevity. They represent some of the most difficult therapeutic challenges facing the healthcare community. The refractory nature of this family of diseases is rooted in the complexities and genetic underpinnings

Wearable Injectors Positioned to Profit from the Expected Surge in Infusion Proc …

(Nashua, NH) – As drug discovery, development and commercialization continue to produce therapeutic biologicals, device designers are being challenged to address a host of issues that require ingenuity and creative thinking. This ongoing evolution has produced a new class of subcutaneous infusion devices that are designed to be worn by the patient. While allowing patients to self-administer high volume injectables, these devices are also expected to pose a cost-saving alternative

Go To Page     111 110 109 108 107 106 105 104 103 102